1971 Senate Hearing on the Drug Listing Act
July 20, 2026
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The hearing addressed the legislative framework for S. 2167 and H.R. 9936, which aimed to amend the Federal Food, Drug, and Cosmetic Act to ensure the FDA maintains an accurate, current list of all drug products in the marketplace.
Potentially affected actors named in the source documents. Mention is not a position.
Drug manufacturers
Registrants under the Federal Food, Drug, and Cosmetic Act would be required to maintain and submit current listings of all drugs they manufacture or process.
Food and Drug Administration (FDA)
The agency would be responsible for managing the updated registry of drug products.
Last recorded activity July 20, 2026.
Next step not available in the current record.
Summary
Key Facts
- The hearing was held on December 8, 1971, by the Senate Committee on Labor and Public Welfare.
- The session focused on two pieces of legislation: S. 2167 and H.R. 9936.
- The proposed legislation seeks to amend the Federal Food, Drug, and Cosmetic Act.
- The primary goal of the bills is to require a current, comprehensive listing of every drug manufactured, prepared, propagated, compounded, or processed by a registrant under the Act.
Frequently Asked Questions
What was the purpose of this hearing?
What law was being amended?
Why It Matters
The hearing addressed the legislative framework for S. 2167 and H.R. 9936, which aimed to amend the Federal Food, Drug, and Cosmetic Act to ensure the FDA maintains an accurate, current list of all drug products in the marketplace.
News Coverage
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Standardization of Drug Oversight
The hearing marks a transition toward centralized, mandatory reporting of all drug products to improve federal oversight of the pharmaceutical industry.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance60How much this matters to a regular citizen
- Controversy10Intensity of disagreement among stakeholders
- Entertainment5Compellingness for a non-policy-wonk reader
- Buzz5Current news / social attention level
Publisher tools